Boxer Capital, LLC Uni Qure N.V. Transaction History

Boxer Capital, LLC

$1.88 Billion
Q3 2024

A detailed history of Boxer Capital, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Boxer Capital, LLC holds 2,225,000 shares of QURE stock, worth $15 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

2,225,000

Holding current value

$15 Million

% of portfolio

0.58%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $8.41 Million - $22.5 Million	2,225,000 New	2,225,000 $11 Million
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $6.5 Million - $9.56 Million	-250,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $18.2 Million - $26.1 Million	-515,400 Reduced 67.34%	250,000 $9.03 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $3.71 Million - $7.46 Million	-100,000 Reduced 11.56%	765,400 $54.8 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $9.84 Million - $19.2 Million	250,000 Added 40.62%	865,400 $34.1 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $17.7 Million - $27.5 Million	-334,600 Reduced 35.22%	615,400 $48.1 Million
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $6.85 Million - $17.1 Million	-250,000 Reduced 20.83%	950,000 $56.7 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $27.4 Million - $40.7 Million	1,200,000 New	1,200,000 $34.6 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$32.1 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$18.8 Million
0.81% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$14.8 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$13 Million
0.02% of portfolio
Black Rock Inc. New York, NY

1.93M
Shares

$13 Million
0.0% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $315M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Account